Clinical Trials Browser

Phase 3 × INDUSTRY × Diarrhea × Clear all

NCT02819960 2022-12-14

Prevention of Irinotecan Induced Diarrhea by Probiotics

Phase 3 Completed

Diarrhea, Neoplasms

NCT00774930 2022-10-14

ELECT

Phase 3 Completed

115 enrolled 17 charts

Carcinoid Tumor, Diarrhea, Flushing, Neuroendocrine Tumors, Serotonin Syndrome

NCT00582426 2015-05-04

LARCID

Phase 3 Completed

139 enrolled 17 charts

Gastrointestinal

Diarrhea, Colorectal Neoplasms

NCT01410955 2014-01-23

Prevention of Irinotecan Induced Diarrhea by Probiotics

Phase 3 Completed

Gastrointestinal

Colonic Neoplasms, Diarrhea, Colorectal Neoplasms

NCT00006269 2012-05-25

Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer

Phase 3 Terminated

Gastrointestinal

Colonic Neoplasms, Diarrhea, Rectal Neoplasms, Colorectal Neoplasms